Today on MedNet21, we're going to discuss Kidney and Bladder Cancer. This webcast will teach on risk factors for and epidemiology bladder cancer, overview of treatment options based on bladder cancer stage and grade, and preliminary workup of hematuria including when to refer to urology. Also, the learner should learn the epidemiology, evaluation and treatment of patients with kidney cancer.
Dates and Times
End Date: 4/15/2025
ObjectivesAs a result of this educational activity, webcast participants will be able to: recognize how to evaluate hematuria, including when to refer for cystoscopy and upper urinary tract imaging; describe how bladder cancer treatments vary widely based on stage and grade; describe the treatment options for kidney cancer; and describe the appropriate radiographic evaluation of a renal mass.
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.